Abstract: The present invention is based on the fusion of FimH, CsgA and PapG adhesins (type 1 Fimbriae, curli and P, respectively) to generate biomolecules that can be used as vaccines against UTIs. Briefly, the invention is based on the design of a fusion template gene fimH-csgA-papG-fimH-csgA and defined as fcpfc to generate the different combinations of monomeric [FimH, CsgA and PapG], dimeric [FimH-CsgA (FC), CsgA-PapG (CP) and PapG-FimH (PF)] and trimeric (FimH-PapG-CsgA (FCP), PapG-CsgA-FimH (PCF) and CsgA-FimH-PapG (CFP)] proteins. Bioactivity was determined by the antibodies present in UP sera and urine, the quantification in the release of cytokines and adhesion inhibition assays.

Abstract: The present invention is based on the fusion of FimH, CsgA and PapG adhesins (type 1 Fimbriae, curli and P, respectively) to generate biomolecules that can be used as vaccines against UTIs. Briefly, the invention is based on the design of a fusion template gene fimH-csgA-papG-fimH-csgA and defined as fcpfc to generate the different combinations of monomeric [FimH, CsgA and PapG], dimeric [FimH-CsgA (FC), CsgA-PapG (CP) and PapG-FimH (PF)] and trimeric (FimH-PapG-CsgA (FCP), PapG-CsgA-FimH (PCF) and CsgA-FimH-PapG (CFP)] proteins. Bioactivity was determined by the antibodies present in UP sera and urine, the quantification in the release of cytokines and adhesion inhibition assays.

Abstract: Aspects of the present disclosure involve a testing device/apparatus configured to test various issues caused by or otherwise associated with pinched wires when two halves of a hot half tool are assembled.

Abstract: Aspects of the present disclosure involve a testing device or apparatus configured to test PTP contacts of user-specified cables capable of transmitting electrical signals along a particular path between two points, such as between a transmitter and a receiver.

Abstract: Aspects of the present disclosure involve a testing device or apparatus configured to test PTP contacts of user-specified cables capable of transmitting electrical signals along a particular path between two points, such as between a transmitter and a receiver.

Abstract: An acoustic assembly includes a plurality of first slats and at least one second slat couplable with each one of the first slats for intersecting with each first slat. Each slat is preferably made from a substrate of a rigid or a semi-rigid material and has oppositely disposed second end portions. An engagement portion is coupled with each first and second end portion for resting atop at least one architectural element for supporting the acoustic assembly. The assembly may include a shear portion and a catch portion for providing a locking mechanism for further securing the first slats with the second slats. When the acoustic canopy is supported from the first and second end portions, the slats may sag to compress open-ended slots of the second slats for pinching the corresponding ones of the first slats received within the open-ended slots.

Abstract: Aspects of the present disclosure involve a testing device or apparatus configured to test PTP contacts of user-specified cables capable of transmitting electrical signals along a particular path between two points, such as between a transmitter and a receiver.

Abstract: Composite structures and a method for improving the electromagnetic characteristics of composite structures produces epoxy nanofibres during the lay-up of structural elements of carbon fibre composite laminates. The epoxy nanofibres are fabricated by electro-spinning and may be doped with carbon nanotubes or other conducting nanoparticles. The nanofibres are selectively applied to one or more carbon fibre plys in a controlled manner of distribution.

Abstract: The present invention relates to compounds of the formula: ##STR1## in which X.sub.1 and X.sub.2 correspond to H or F without distinction; R.sub.1 represents the following radicals: ##STR2## and R.sub.2 represents the radicals ##STR3## in the form of an R epimer, an S epimer, or a stereoisomeric mixture of the R and S epimers in terms of the orientation of the substituents on the carbon atom at position 22, novel intermediates and a method of their preparation by hydrolysis-ketalization, and use of such compounds as drugs and/or therapeutic agents.

Abstract: An application of .alpha.-[[(2-hydroxy-1, 1-dimethyl-ethyl) amine] methyl] enzene methanol hydrochloride (EL-508), as a compound with antiinflammatory action, as well as the different pharmaceutical compositions in which the referred compound is the active principle and its use in therapeutics as an antiinflammatory drug.